Improving treatment for people with kidney transplants

CAMPATH, Calcineurin inhibitor reduction and Chronic allograft nephropathy trial

PATIENT INFORMATION SHEET

Information about a study you might be asked to join

This detailed information is broken into two parts. A summary of the two parts follows below.

To read part 1, click here.

To read part 2, click here.

Summary of invitation to take part in the 3C Study

THANK YOU FOR YOUR HELP.

transparent area to click on